- Home
- MAN vs MLTX Comparison
MAN vs MLTX Comparison
Compare MAN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAN
- MLTX
- Stock Information
- Founded
- MAN 1948
- MLTX 2021
- Country
- MAN United States
- MLTX Switzerland
- Employees
- MAN N/A
- MLTX N/A
- Industry
- MAN Professional Services
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- MAN Consumer Discretionary
- MLTX Health Care
- Exchange
- MAN Nasdaq
- MLTX Nasdaq
- Market Cap
- MAN 2.8B
- MLTX 2.8B
- IPO Year
- MAN 1988
- MLTX N/A
- Fundamental
- Price
- MAN $53.78
- MLTX $42.33
- Analyst Decision
- MAN Hold
- MLTX Strong Buy
- Analyst Count
- MAN 6
- MLTX 7
- Target Price
- MAN $69.33
- MLTX $84.20
- AVG Volume (30 Days)
- MAN 756.1K
- MLTX 336.5K
- Earning Date
- MAN 04-17-2025
- MLTX 02-27-2025
- Dividend Yield
- MAN 5.72%
- MLTX N/A
- EPS Growth
- MAN 71.02
- MLTX N/A
- EPS
- MAN 3.01
- MLTX N/A
- Revenue
- MAN $17,853,900,000.00
- MLTX N/A
- Revenue This Year
- MAN N/A
- MLTX N/A
- Revenue Next Year
- MAN $3.70
- MLTX N/A
- P/E Ratio
- MAN $17.86
- MLTX N/A
- Revenue Growth
- MAN N/A
- MLTX N/A
- 52 Week Low
- MAN $53.68
- MLTX $37.55
- 52 Week High
- MAN $78.87
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- MAN 30.19
- MLTX 39.31
- Support Level
- MAN $53.71
- MLTX $41.01
- Resistance Level
- MAN $55.40
- MLTX $45.01
- Average True Range (ATR)
- MAN 1.27
- MLTX 1.99
- MACD
- MAN -0.34
- MLTX -0.08
- Stochastic Oscillator
- MAN 1.82
- MLTX 17.53
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that includes Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives maximum of the company's revenue. The company derives maximum geographical revenue from Southern European region.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.